Form 8-K - Current report:
SEC Accession No. 0001193125-24-237150
Filing Date
2024-10-15
Accepted
2024-10-15 06:10:08
Documents
68
Period of Report
2024-10-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d858952d8k.htm   iXBRL 8-K 41201
2 EX-10.1 d858952dex101.htm EX-10.1 206370
3 EX-10.2 d858952dex102.htm EX-10.2 190434
4 EX-10.3 d858952dex103.htm EX-10.3 97571
5 EX-99.1 d858952dex991.htm EX-99.1 21380
6 EX-99.2 d858952dex992.htm EX-99.2 51230
10 GRAPHIC g858952ex99_2p10g1.jpg GRAPHIC 329768
11 GRAPHIC g858952ex99_2p11g1.jpg GRAPHIC 182473
12 GRAPHIC g858952ex99_2p12g1.jpg GRAPHIC 301267
13 GRAPHIC g858952ex99_2p13g1.jpg GRAPHIC 255216
14 GRAPHIC g858952ex99_2p14g1.jpg GRAPHIC 302343
15 GRAPHIC g858952ex99_2p15g1.jpg GRAPHIC 318849
16 GRAPHIC g858952ex99_2p16g1.jpg GRAPHIC 200387
17 GRAPHIC g858952ex99_2p17g1.jpg GRAPHIC 240891
18 GRAPHIC g858952ex99_2p18g1.jpg GRAPHIC 265970
19 GRAPHIC g858952ex99_2p19g1.jpg GRAPHIC 304306
20 GRAPHIC g858952ex99_2p1g1.jpg GRAPHIC 236790
21 GRAPHIC g858952ex99_2p20g1.jpg GRAPHIC 242444
22 GRAPHIC g858952ex99_2p21g1.jpg GRAPHIC 195827
23 GRAPHIC g858952ex99_2p22g1.jpg GRAPHIC 207088
24 GRAPHIC g858952ex99_2p23g1.jpg GRAPHIC 287032
25 GRAPHIC g858952ex99_2p24g1.jpg GRAPHIC 310254
26 GRAPHIC g858952ex99_2p25g1.jpg GRAPHIC 246877
27 GRAPHIC g858952ex99_2p26g1.jpg GRAPHIC 260931
28 GRAPHIC g858952ex99_2p27g1.jpg GRAPHIC 343110
29 GRAPHIC g858952ex99_2p28g1.jpg GRAPHIC 324409
30 GRAPHIC g858952ex99_2p29g1.jpg GRAPHIC 190667
31 GRAPHIC g858952ex99_2p2g1.jpg GRAPHIC 770559
32 GRAPHIC g858952ex99_2p30g1.jpg GRAPHIC 255796
33 GRAPHIC g858952ex99_2p31g1.jpg GRAPHIC 247368
34 GRAPHIC g858952ex99_2p32g1.jpg GRAPHIC 256428
35 GRAPHIC g858952ex99_2p33g1.jpg GRAPHIC 256373
36 GRAPHIC g858952ex99_2p34g1.jpg GRAPHIC 240835
37 GRAPHIC g858952ex99_2p35g1.jpg GRAPHIC 185623
38 GRAPHIC g858952ex99_2p36g1.jpg GRAPHIC 158726
39 GRAPHIC g858952ex99_2p37g1.jpg GRAPHIC 240817
40 GRAPHIC g858952ex99_2p38g1.jpg GRAPHIC 244275
41 GRAPHIC g858952ex99_2p39g1.jpg GRAPHIC 266970
42 GRAPHIC g858952ex99_2p3g1.jpg GRAPHIC 258980
43 GRAPHIC g858952ex99_2p40g1.jpg GRAPHIC 275451
44 GRAPHIC g858952ex99_2p41g1.jpg GRAPHIC 190142
45 GRAPHIC g858952ex99_2p42g1.jpg GRAPHIC 376039
46 GRAPHIC g858952ex99_2p43g1.jpg GRAPHIC 256714
47 GRAPHIC g858952ex99_2p44g1.jpg GRAPHIC 228329
48 GRAPHIC g858952ex99_2p45g1.jpg GRAPHIC 321603
49 GRAPHIC g858952ex99_2p46g1.jpg GRAPHIC 261339
50 GRAPHIC g858952ex99_2p47g1.jpg GRAPHIC 244327
51 GRAPHIC g858952ex99_2p48g1.jpg GRAPHIC 188924
52 GRAPHIC g858952ex99_2p49g1.jpg GRAPHIC 236879
53 GRAPHIC g858952ex99_2p4g1.jpg GRAPHIC 244397
54 GRAPHIC g858952ex99_2p5g1.jpg GRAPHIC 200627
55 GRAPHIC g858952ex99_2p6g1.jpg GRAPHIC 363185
56 GRAPHIC g858952ex99_2p7g1.jpg GRAPHIC 302144
57 GRAPHIC g858952ex99_2p8g1.jpg GRAPHIC 258211
58 GRAPHIC g858952ex99_2p9g1.jpg GRAPHIC 264010
59 GRAPHIC g858952g1014153403050.jpg GRAPHIC 3643
  Complete submission text file 0001193125-24-237150.txt   18990971

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA syre-20241011.xsd EX-101.SCH 2833
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE syre-20241011_lab.xml EX-101.LAB 18758
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syre-20241011_pre.xml EX-101.PRE 11699
70 EXTRACTED XBRL INSTANCE DOCUMENT d858952d8k_htm.xml XML 3776
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37722 | Film No.: 241369027
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)